Literature DB >> 9099788

Immunoadhesins as research tools and therapeutic agents.

A Ashkenazi1, S M Chamow.   

Abstract

An immunoadhesin is a fusion protein that combines the target-binding region of a receptor, an adhesion molecule, a ligand, or an enzyme, with the Fc region of an Ig. Immunoadhesins provide a unique tool for identifying unknown binding targets and for elucidating molecular interactions that control biological function. Recent studies suggest that immunoadhesins also may be useful therapeutically, as inhibitors of autoimmune and inflammatory diseases.

Mesh:

Substances:

Year:  1997        PMID: 9099788     DOI: 10.1016/s0952-7915(97)80135-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  17 in total

1.  Inhibition of foam cell formation using a soluble CD68-Fc fusion protein.

Authors:  Karin Daub; Dorothea Siegel-Axel; Tanja Schönberger; Christoph Leder; Peter Seizer; Karin Müller; Martin Schaller; Sandra Penz; Dagmar Menzel; Berthold Büchele; Andreas Bültmann; Götz Münch; Stephan Lindemann; Thomas Simmet; Meinrad Gawaz
Journal:  J Mol Med (Berl)       Date:  2010-05-08       Impact factor: 4.599

2.  Pathway-specific engagement of ephrinA5-EphA4/EphA5 system of the substantia nigra pars reticulata in cocaine-induced responses.

Authors:  Kensuke Kimura; Takatoshi Hikida; Satoshi Yawata; Takashi Yamaguchi; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

Review 3.  Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.

Authors:  Ruth Elena Soria-Guerra; Leticia Moreno-Fierros; Sergio Rosales-Mendoza
Journal:  Plant Cell Rep       Date:  2011-04-20       Impact factor: 4.570

Review 4.  Adeno-associated virus delivery of broadly neutralizing antibodies.

Authors:  Bruce C Schnepp; Philip R Johnson
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

5.  Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies.

Authors:  Olga S Latinovic; Sandra Medina-Moreno; Kate Schneider; Neelakshi Gohain; Juan Zapata; Marzena Pazgier; Marvin Reitz; Joseph Bryant; Robert R Redfield
Journal:  AIDS Res Hum Retroviruses       Date:  2015-06-22       Impact factor: 2.205

6.  Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc.

Authors:  Olga Latinovic; Kate Schneider; Henryk Szmacinski; Joseph R Lakowicz; Alonso Heredia; Robert R Redfield
Journal:  Antiviral Res       Date:  2014-10-24       Impact factor: 5.970

7.  TRAF2 is a biologically important necroptosis suppressor.

Authors:  S L Petersen; T T Chen; D A Lawrence; S A Marsters; F Gonzalvez; A Ashkenazi
Journal:  Cell Death Differ       Date:  2015-04-17       Impact factor: 15.828

8.  The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE.

Authors:  Yi Shu; Bo Xiao; Qian Wu; Tiantian Liu; Yang Du; Haiyun Tang; Si Chen; Li Feng; Lili Long; Yi Li
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

9.  Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.

Authors:  Keith L Wycoff; Archana Belle; Dorothée Deppe; Leah Schaefer; James M Maclean; Simone Haase; Anke K Trilling; Shihui Liu; Stephen H Leppla; Isin N Geren; Jennifer Pawlik; Johnny W Peterson
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

10.  Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants.

Authors:  Zhe Lu; Kyung-Jin Lee; Yingxue Shao; Jeong-Hwan Lee; Yangkang So; Young-Kug Choo; Doo-Byoung Oh; Kyung-A Hwang; Seung Han Oh; Yeon Soo Han; Kisung Ko
Journal:  J Biomed Biotechnol       Date:  2012-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.